Join
Live feed
·
PRReleasevia Quantisnow
Third Harmonic Bio Inc. logo

Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update

ByQuantisnow·Wall Street's wire, on your screen.
THRD· Third Harmonic Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track THRD (Third Harmonic Bio Inc.) and more on Quantisnow.